Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Veterinary Clinics: Small Animal PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Beta-cell function and insulin secretion.in: Porte D. Sherwin R. Baron A. Ellenberg & rifkin’s diabetes mellitus. The McGrew-Hill Companies Inc, New York2003
- Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.Diabetes Technol Ther. 2008; 10: 333-349
- Mechanisms of insulin action and insulin resistance.Physiol Rev. 2018; 98: 2133-2223
- Insulin analogues: an example of applied medical science.Diabetes Obes Metabol. 2009; 11: 5-19
- Texturized vegetable protein containing indigestible soy carbohydrate affects blood insulin concentrations in dogs fed high fat diets.J Nutr. 2006; 136: 2024S-2027S
Carciofi AC, Takakura FS, de-Oliveira LD, et al., Effects of six carbohydrate sources on dog diet digestibility and post-prandial glucose and insulin response, J Anim Physiol Anim Nutr, 2008;92:326–336.
- A diet lower in digestible carbohydrate results in lower postprandial glucose concentrations compared with a traditional canine diabetes diet and an adult maintenance diet in healthy dogs.Res Vet Sci. 2012; 93: 288-295
- Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain.J Feline Med Surg. 2001; 3: 211-228
- Comparison of three commercially available prescription diet regimens on short-term post-prandial serum glucose and insulin concentrations in healthy cats.Vet Res Commun. 2009; 33: 669-680
- Effects of six carbohydrate sources on diet digestibility and postprandial glucose and insulin responses in cats.J Anim Sci. 2008; 86: 2237-2246
- The daytime feeding frequency affects appetite-regulating hormones, amino acids, physical activity, and respiratory quotient, but not energy expenditure, in adult cats fed regimens for 21 days.PLoS One. 2020; 15e0238522
- American Diabetes Association, 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020.Diabetes Care. 2020; 43: S98-S110
- Diabetic remission in a cat treated with an implantable pump to deliver insulin.The Canadian veterinary journal = La revue veterinaire canadienne. 2020; 61: 30-34
- Connecting rodent and human pharmacokinetic models for the design and translation of glucose-responsive insulin.Diabetes. 2020; 69: 1815-1826
- Does insulin detemir have a role in reducing risk of insulin-associated weight gain?.Diabetes Obes Metabol. 2007; 9: 209-217
- Euglycaemic glucose clamp: what it can and cannot do, and how to do it.Diabetes Obes Metabol. 2016; https://doi.org/10.1111/dom.12703
- Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.Diabetes Obes Metabol. 2008; 10: 484-491
- The evolution of insulin and how it informs therapy and treatment choices.Endocr Rev. 2020; 41: 733-755
- The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin.Pharm Res (N Y). 2004; 21: 1498-1504
- Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.Drug Metab Dispos. 2000; 28: 155-160
- Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin.Diabetes Obes Metabol. 2009; 11: 715-720
- Hyperinsulinemic-euglycemic clamps using insulin detemir and insulin glargine in healthy cats [abstract].J Vet Intern Med. 2008; 22: 729
- Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens.Lancet (London, England). 1999; 354: 1604-1607
- Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.Diabetes. 2004; 53: 1614-1620
- pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.Peptides. 2007; 28: 935-948
- Low within- and between-day variability in exposure to new insulin glargine 300 U/ml.Diabetes Obes Metabol. 2015; https://doi.org/10.1111/dom.12416
- Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml.Diabetes Obes Metabol. 2014; https://doi.org/10.1111/dom.12283
- New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: Glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).Diabetes Care. 2014; https://doi.org/10.2337/dc14-0991
- Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes.Diabetes Obes Metabol. 2015; https://doi.org/10.1111/dom.12485
- Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies.Diabetes Obes Metabol. 2007; 9: 648-659
- Insulin detemir: a new basal insulin analogue.Diabetes Obes Metabol. 2006; 8: 26-30
- Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial.Pediatr Diabetes. 2008; 9: 554-560
- Indirect comparison of once daily insulin detemir and glargine in reducing weight gain and hypoglycaemic episodes when administered in addition to conventional oral anti-diabetic therapy in patients with type-2 diabetes.Pharmacology. 2008; 82: 156-163
- Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.Diabetes Res Clin Pract. 2008; 81: 184-189
- Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats.J Vet Intern Med. 2010, 870-874; 24
- Pharmacodynamics and pharmacokinetics of insulin detemir and insulin glargine 300 U/mL in healthy dogs.Domest Anim Endocrinol. 2018, 17-30; 64
- Time-action profiles of insulin detemir in normal and diabetic dogs.Res Vet Sci. 2011; 90: 396-403
- Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.Diabetes Obes Metabol. 2017; 19: 1032-1039
- Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs.J Vet Med Sci. 2018; 80: 1720-1723
- Comparison of pharmacodynamics and pharmacokinetics of insulin degludec and insulin glargine 300 U/mL in healthy cats.Domest Anim Endocrinol. 2019; 69: 19-29
- The Neonatal Fc Receptor (FcRn): A Misnomer?.Front Immunol. 2019; 10: 1540
- FcRn: the neonatal Fc receptor comes of age.Nat Rev Immunol. 2007; 7: 715-725
- An ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in cats.J Vet Intern Med. 2021; 35: 2123-2130
- Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs.J Vet Intern Med. 2022; https://doi.org/10.1111/jvim.16449
- Breed differences in development of anti-insulin antibodies in diabetic dogs and investigation of the role of dog leukocyte antigen (DLA) genes.Vet Immunol Immunopathol. 2015; 167: 130-138
- Beta cell and insulin antibodies in treated and untreated diabetic cats.Vet Immunol Immunopathol. 2000; 77: 93-102
- Medication compliance and persistence: terminology and definitions, Value Heal.J. Int. Soc. Pharmacoeconomics Outcomes Res. 2008; 11: 44-47
- Self-reported barriers to adherence and persistence to treatment with injectable medications for type 2 diabetes.Clin Therapeut. 2016; 38: 1653-1664.e1
- Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.Patient Prefer Adherence. 2018; 12: 707-719
- Barriers to insulin injection therapy: patient and health care provider perspectives.Diabetes Educat. 2009; 35: 1014-1022
- Evaluation of a quality-of-life tool for dogs with diabetes mellitus.J Vet Intern Med. 2012; 26: 953-961
- Evaluation of a quality-of-life tool for cats with diabetes mellitus.J Vet Intern Med. 2010; 24: 1098-1105
- The big pet diabetes survey: perceived frequency and triggers for euthanasia.Vet. Sci. 2017, 27; 4
- Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.J Vet Intern Med. 2007; 21: 1209-1216
- Adherence to medication.N Engl J Med. 2005; 353: 487-497
- Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.Expet Opin Drug Deliv. 2008; 5: 915-925
- Analysis of symposium articles on insulin pen devices and alternative insulin delivery methods.J. Diabetes Sci. Technol. 2010; 4: 558-561
- Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.Diabetes Technol Ther. 2010; 12: S101-S108
- Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.Pharmacotherapy. 2007; 27: 948-962
- Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.Clin Therapeut. 2006; 28: 1711-1712
- Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes.Arch Dis Child. 1998; 79: 59-62
- Dosing accuracy of insulin pens versus conventional syringes and vials.Diabetes Technol Ther. 2010; 12: S73-S77
- Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump.Clin Pediatr. 2004; 43: 69-74
- Comparison of precision and accuracy of U100 and U40 insulin syringes [Abstract].J Vet Intern Med. 2014; 28: 1029
- Accuracy and precision of low-dose insulin administration.Pediatrics. 1993; 91: 1155-1157
Burgaud S, Guillot R, Harnois-Milon G. Clinical evaluation of a veterinary insulin pen in diabetic dogs. In: Proceedings of the WSAVA/ FECAVA/BSAVA congress; 12-15 April 2012; Birmingham, UK. Abstract 122.
- Glycemic control and owner preference in insulin delivery in diabetic dogs (Abstract).J Vet Intern Med. 2020; 34: 3134
- Update on insulin treatment for dogs and cats: insulin dosing pens and more.Vet Med (Auckland, N.Z). 2015; 6: 129-142
- 10-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Med. 2008; 359: 1577-1589
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med. 1993; 329: 977-986
- American Diabetes Association, 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018.Diabetes Care. 2018; 41: S55-S64
- Pharmacodynamics and pharmacokinetics of insulin aspart assessed by use of the isoglycemic clamp method in healthy cats.Domest Anim Endocrinol. 2018; 62
- Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.J Artif Organs. 2003; 6: 55-63
- Effects of treatment with lispro and neutral protamine Hagedorn insulins on serum fructosamine and postprandial blood glucose concentrations in dogs with clinically well-controlled diabetes mellitus and postprandial hyperglycemia.Am J Vet Res. 2020; 81: 153-158
- Glucose lowering effects of inhaled insulin in healthy cats.J Feline Med Surg. 2008; 10: 519-522
Article info
Publication history
Published online: March 09, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
